Somatropin biosimilar (BioPartners GmbH)

生长激素生物类似药 (BioPartners GmbH)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSomatropin biosimilar (BioPartners GmbH)
Drug Alias Name生长激素生物仿制药 (BioPartners GmbH)ValtropinrhGH (BioPartners GmbH)SR-rhGH (BioPartners GmbH)LB-03002
ClassificationBiologics > Biosimilar
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiencyTurner SyndromePrader-Willi Syndrome +[5] 
Global Approved IndicationsGrowth hormone deficiencyTurner SyndromeDwarfism, Pituitary
Approved Indications in ChinaGrowth hormone deficiency
Original Approved Country/TerritoryEU
Original Approved Date2006/04/24
Country/TerritoryUnited StatesSouth KoreaEU +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBiopartners GmbhLg Chemical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLg Chemical Ltd
Inactive CompaniesBiopartners Gmbh
Active IndicationsGrowth hormone deficiency
Inactive IndicationsTurner SyndromePrader-Willi SyndromePituitary Diseases +[4] 

Other Information

ATC CodeH01AC01
Related LinksN/A